Portfolio company
Exolvo Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
Nexos
Nexos Biosciences develops exosome-based drug delivery systems for pharmaceutical companies to enable oral administration of treatments for cancer, inflammation, and metabolic diseases.
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
Drug Delivery
This company develops ingestible technology for drug delivery and health monitoring to serve patients and healthcare providers.
SEncIL
SEncIL develops encapsulation technology that transforms liquid drugs into polymer-encapsulated powders to improve oral drug delivery for pharmaceutical companies.
Rani
Rani Therapeutics develops oral capsules that deliver biologic medicines directly into the intestinal wall for patients with chronic conditions requiring regular injections.
ExcepGen
ExcepGen develops a platform for nucleic acid therapeutics to improve the efficacy and tolerability of mRNA-based medicines for biopharmaceutical companies.
InkVivo
The company develops polymer-based drug delivery systems for pharmaceutical and nutraceutical industries to enhance therapeutic adherence and efficacy.